Oncology Pipeline Director

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. ​

We prevent and treat disease with specialty medicines, vaccines and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas – respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale. ​

​

People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can perform and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.

GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on people’s health. ​

Our strategy is to prevent and treat disease with specialty medicines, vaccines and general medicines. ​​

We combine the science of the immune system with advanced technologies, enhanced by targeted business development and world-class partnerships, to develop new medicines and vaccines that can help transform people’s lives.

The Oncology Pipeline Director is responsible for representing the Canadian commercial perspective across the lifecycle of a broad portfolio of novel oncology assets and indications, including multiple brands in key tumor types, from early development through launch and post-launch optimization. This high-profile role serves as the primary Canadian commercial leader interfacing with global and regional asset and marketing teams for all relevant oncology assets, providing strategic guidance and input on Canadian needs for commercial readiness, market access and launch excellence, and ensuring asset and indication value is maximized for Canada.

The Director will work cross-functionally with Medical Affairs, Market Access, Regulatory, Business Intelligence and other stakeholders in Canada to shape the development path and commercialization strategy for this multi-brand oncology portfolio, including prioritization across assets, resource and investment allocation and timing, and business case / P&L development. The role requires deep expertise in Canadian oncology market dynamics, competitive intelligence and the payer landscape, as well as demonstrated commercial launch excellence across multiple assets. The Director will ensure the Canadian perspective is considered, built into global and regional strategy, and effectively localized for execution.

• →Serve as the Canadian commercial lead for a portfolio of oncology assets, indications and brands at different lifecycle stages (pre-launch, launch and in-line) on global and regional teams, ensuring the Canadian perspective is considered in development and commercialization decisions.
• →Lead Canadian commercial strategy for a multi-brand oncology portfolio, including several assets with overlapping launch timelines over the next 2–4 years.
• →Shape Canadian positioning strategy, value proposition and differentiation relative to current and emerging competitors for each priority asset and tumor type.
• →Act as a member of the Oncology Leadership Team.
• →Translate Canadian market insights into actionable strategy for local and global / regional teams as needed.
• →Partner with local Medical and Clinical teams to ensure understanding of local drivers and barriers to success of clinical trial sites in Canada and implications for potential commercial success or needs.
• →Identify opportunities to optimize label potential and market access positioning.
• →Represent Canada on selected global oncology asset and global marketing teams, building strong relationships and proactively shaping global strategy, evidence plans and launch readiness to enable Canadian success.

• Lead the cross-functional team for Canada for market landscape assessments, including:
  • Disease epidemiology
  • Treatment paradigms
  • Competitive intelligence
• Monitor evolving competitive pipelines across key tumor types (e.g., Lung, Gynecological, GI, GU and other solid and hematologic malignancies), translating insights into portfolio-level strategic implications for positioning, sequencing, resource allocation and investment decisions.
• Integrate clinical, market access and real-world performance data to continuously refine Canadian brand and indication strategies.
  

• Collaborate with Business Intelligence to develop robust Canadian forecasts and scenario planning.
• Lead assessment of commercial opportunity, pricing potential and market uptake dynamics for multiple oncology assets and indications, and own or co-own the Canadian forecast assumptions for these brands.
• Provide strategic input into investment decisions and lifecycle planning.
• Drive portfolio-level scenario planning (e.g., launch sequencing, label evolution, competitive entries) and articulate clear implications for Canadian revenues, margin and investment.

• Serve as a key integrator across:
  • Oncology Commercial Leadership
  • Medical Affairs
  • Market Access
  • Regulatory
  • Business Intelligence
• Drive alignment and integrated strategic plan development across stakeholders to ensure timely and strategic decision making.
• Provide day-to-day leadership and coaching to a commercial pipeline / brand team while orchestrating a broader cross-functional matrix across Canadian and global stakeholders.
• Navigate complex global–local matrix structures and ensure a seamless flow of information and decisions between Canada and global / regional asset and marketing teams.

• Strategic thinking and ability to translate insights into actionable portfolio-level, multi-brand strategy
• Enterprise leadership across complex global matrix organizations
• Strong commercial acumen in oncology markets, including launch excellence and market access
• Influencing without authority, including global asset and marketing teams
• Data-driven decision making, including forecasting and scenario planning across multiple assets
• Proven ability to operate at pace and prioritize effectively across competing oncology brand demands

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.

People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.

GSK is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law. GSK is committed to accommodating persons with disabilities. If you need accommodation at any stage of the application process or want more information on our accommodation policies, please contact us at canada-recruitment@gsk.com.  Please do not send resumes to this e-mail and instead apply through the online application process of this posting.

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.